Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae

• Published in: BMC infectious diseases Vol. 19; no. 1; pp. 772 - 6
• Main Authors: Alraddadi, Basem M., Saeedi, Mohammed, Qutub, Mohammed, Alshukairi, Abeer, Hassanien, Ashraf, Wali, Ghassan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.09.2019; BioMed Central; BMC
• Subjects: Avibactam; Bacteremia; Carbapenem-resistant Enterobacteriaceae; Care and treatment; Ceftazidime; Ceftazidime-avibactam; Cohort analysis; Comorbidity; Enterobacteriaceae infections; Genes; Imipenem; Infection; Medical research; Mortality; Oxalic acid; Pneumonia; Risk factors; Saudi Arabia; Saudi Arabia; Carbapenem-resistant Enterobacteriaceae; Ceftazidime-avibactam

Carbapenem-resistant Enterobacteriaceae (CRE) represent an important global threat. The aim of this study is to describe the clinical course and outcomes of patients with CRE infections treated with ceftazidime-avibactam (CAZ-AVI) compared to patients treated with other agents. A retrospective cohor...